3 things you need to know about Australia and New Zealand Banking Group's profit results

The market is relieved that Australia and New Zealand Banking Group (ASX: ANZ) posted a respectable increase in cash profit but its isn't the bottom-line investors should be focused on.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shareholders will be breathing a little easier after Australia and New Zealand Banking Group (ASX: ANZ) reported a respectable increase in earnings that was a little ahead of consensus this morning.

But this bank reporting season isn't really about bottom lines per se. There are other things the market is paying more attention to at the moment and in ANZ Bank's case, it's the prospect of more share buybacks and management has come to the party empty-handed.

It's not that the bank could not afford to expand the ongoing $1.5 billion share buyback given the strength of its balance sheet with management posting a respectable 4.1% increase in the bank's underlying cash profit to $3.49 billion for the six months to end March 2018.

The increase in earnings has helped bolster the bank's Common Equity Tier-1 (CET) ratio to 11% from 10.1% in the first half of FY17.

But management has decided to take a more conservative approach and given the intense scrutiny that the bank and industry is under from the Banking Royal Commission, it's understandable that they would have a bit of a siege mentality.

I can't help but think that their spin-doctors advised them not to splash cash around during this trying period with ANZ Bank keeping its interim dividend flat at 80 cents a share even though the increase in profit should have theoretically allowed it to cough up a little more to appease embattled shareholders.

However, management did hint that shareholders can expect more buybacks or other capital management announcements after it completes further asset sales.

The second thing worth noting from the results is margin pressure as the bank reported a pretty significant 7 basis point decrease in net interest margin (NIM) to 1.93%.

This is more than what I was expecting (and I suspect it is more than what the market was expecting too) although the bank did point out that NIM would have only dipped 1 basis point if certain businesses were excluded. How convenient.

Rising costs is a growing issue in the sector, particularly as banks are facing rising funding costs and other expenses such as legal fees from the Royal Commission and lawsuits.

The third takeaway from ANZ Bank's results is its outlook statement. Management is sticking with the "difficult trading conditions" mantra that it flagged since 2016.

That hasn't stopped the bank from growing its cash profit though and some may be inclined to believe the momentum can be sustained.

If anyone can squeeze blood from stone, it's our banks, so I won't be surprised to see another increase in profits going forward.

But I suspect this is as good as it gets for ANZ Bank and its peers in terms of cash profit growth given the prospects of increasing costs, a slowing housing market, record high household debt and weak wages growth.

ANZ Bank's results kicks off the bank reporting season with National Australia Bank Ltd. (ASX: NAB) and Westpac Banking Corp (ASX: WBC) scheduled to announce their interim results over the coming days.

Investment bank Macquarie Group Ltd (ASX: MQG) will also report its results while Commonwealth Bank of Australia (ASX: CBA) has already handed in its results in February.

Motley Fool contributor Brendon Lau owns shares of Australia & New Zealand Banking Group Limited, Macquarie Group Limited, National Australia Bank Limited, and Westpac Banking. The Motley Fool Australia owns shares of National Australia Bank Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »